Non-Phased Study of the Use of a Single Dose of Thymoglobulin for Immunosuppressive Induction in Renal Transplant Recipients as Compared to a Standard Four Dose Regimen.
Phase of Trial: Phase II
Latest Information Update: 27 Oct 2009
At a glance
- Drugs Antithymocyte globulin (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 27 Oct 2009 New trial record